about
Exacerbation of autoimmune hemolytic anemia induced by the first dose of programmed death-1 inhibitor pembrolizumab: a case report.Severe hemolysis and transfusion reactions after treatment with BGB-3111 and PD-1 antibody for Waldenström Macroglobulinemia.Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections.Nivolumab-induced cold agglutinin syndrome successfully treated with rituximab
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunotherapy-associated autoimmune hemolytic anemia.
@en
Immunotherapy-associated autoimmune hemolytic anemia.
@nl
type
label
Immunotherapy-associated autoimmune hemolytic anemia.
@en
Immunotherapy-associated autoimmune hemolytic anemia.
@nl
prefLabel
Immunotherapy-associated autoimmune hemolytic anemia.
@en
Immunotherapy-associated autoimmune hemolytic anemia.
@nl
P2093
P2860
P1476
Immunotherapy-associated autoimmune hemolytic anemia
@en
P2093
Awais Zaka
Farman Ali
Muhammad Siddique Khurram
P2860
P2888
P356
10.1186/S40425-017-0214-9
P577
2017-02-21T00:00:00Z